サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：カンナビノイドの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測
市場調査レポート
商品コード
1342892

カンナビノイドの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測

Global Cannabinoids Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日: | 発行: Value Market Research | ページ情報: 英文 242 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.25円
カンナビノイドの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測
出版日: 2023年08月01日
発行: Value Market Research
ページ情報: 英文 242 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

カンナビノイド市場の世界需要は、2023～2030年の調査期間中、CAGR 25.44%で、2022年の255億4,000万米ドルから2030年には約1,964億米ドルの市場規模に達すると推定されます。

カンナビノイドは医療用マリファナとしても知られ、病気の治療や症状の改善に用いられます。痛み、血圧、記憶力、集中力、食欲、感覚刺激、筋肉の問題、発作など、その他の疾患や健康状態のコントロールに使用されます。また、ボディケア分野では、ボディオイル、ローション、カプセルの成分としても使用されています。

市場力学：

近年、様々な医療疾患に対する大麻の使用が国内で人気を博しています。市場の拡大には、カンナビノイドを含む製品に対する顧客の嗜好の高まりや、大麻および関連製品に対する社会的認知度の向上などの要素が寄与しています。また、カンナビノイドをめぐる政府の好意的な政策も、この業界に参入する企業を増やしています。さらに、マイナー・カンナビノイドやメジャー・カンナビノイドが様々な健康問題の治療に役立つことを示唆する有望な調査により、大麻使用に対する一般市民の意識が高まっています。しかし、特に小カンナビノイドについては、生産と抽出のコストが高く、市場拡大の妨げになると予想されます。

本レポートでは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析を取り上げています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、カンナビノイドの世界市場における各セグメントを包括的に評価することもできます。カンナビノイド産業の成長と動向は、この調査に全体的なアプローチを提供します。

地域分析：

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東＆アフリカのカンナビノイド市場の現在と将来の需要を強調する地域展望をカバーしています。さらに、本レポートは、すべての主要地域における個々のアプリケーションセグメントの需要、推定・予測に焦点を当てています。

特注のご要望がございましたら、弊社までご連絡ください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 カンナビノイド産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 COVID-19発生の影響分析

第6章 カンナビノイドの世界市場分析：製品タイプ別

  • 概要：製品タイプ別
  • 実績データと予測データ
  • 分析：製品タイプ別
  • カンナビジオール
  • テトラヒドロカンナビノール
  • カンナビノール
  • その他

第7章 カンナビノイドの世界市場分析：用途別

  • 概要：用途別
  • 実績データと予測データ
  • 分析：用途別
  • 医薬品用途（慢性疼痛、神経疾患管理、がん、その他）
  • 非医療用

第8章 カンナビノイドの世界市場分析：流通チャネル別

  • 流通チャネル別概要
  • 実績データと予測データ
  • 流通チャネル別分析
  • 病院薬局
  • 小売薬局
  • オンラインストア

第9章 カンナビノイドの世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • その他アジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第10章 カンナビノイド企業の競合情勢

  • カンナビノイド市場の競合
  • 提携／協力／合意
  • 合併・買収
  • 新製品の発売
  • その他の開発

第11章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • Mylan N.V.（Viatris Inc.）
  • Alkem Labs
  • GW Pharmaceuticals plc
  • Tilray Inc.
  • Aurora Cannabis Inc.
  • Canopy Growth Corporation
  • The Cronos Group
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product Type (Tons and USD MN)
  • Cannabidiol Market Sales by Geography (Tons and USD MN)
  • Tetrahydrocannabinol Market Sales by Geography (Tons and USD MN)
  • Cannabinol Market Sales by Geography (Tons and USD MN)
  • Others Market Sales by Geography (Tons and USD MN)
  • Analysis Market by Application (Tons and USD MN)
  • Medicinal Use (Chronic Pain, Neurological Disorders Management, Oncology, Others) Market Sales by Geography (Tons and USD MN)
  • Non-medical Use Market Sales by Geography (Tons and USD MN)
  • Analysis by Distribution Channel (Tons and USD MN)
  • Hospital Pharmacies Market Sales by Geography (Tons and USD MN)
  • Retail Pharmacies Market Sales by Geography (Tons and USD MN)
  • Online Stores Market Sales by Geography (Tons and USD MN)
  • Global Cannabinoids Market Sales by Geography (Tons and USD MN)
  • North America Market Analysis (Tons and USD MN)
  • United State Market Analysis (Tons and USD MN)
  • Canada Market Analysis (Tons and USD MN)
  • Mexico Market Analysis (Tons and USD MN)
  • Europe Market Analysis (Tons and USD MN)
  • Europe Market Estimate by Country (Tons and USD MN)
  • United Kingdom Market Analysis (Tons and USD MN)
  • France Market Analysis (Tons and USD MN)
  • Germany Market Analysis (Tons and USD MN)
  • Italy Market Analysis (Tons and USD MN)
  • Russia Market Analysis (Tons and USD MN)
  • Spain Market Analysis (Tons and USD MN)
  • Rest of Europe Market Analysis (Tons and USD MN)
  • Asia Pacific Market Analysis (Tons and USD MN)
  • China Market Analysis (Tons and USD MN)
  • Japan Market Analysis (Tons and USD MN)
  • India Market Analysis (Tons and USD MN)
  • South Korea Market Analysis (Tons and USD MN)
  • Australia Market Analysis (Tons and USD MN)
  • Rest of Asia Pacific Market Analysis (Tons and USD MN)
  • Latin America Market Analysis (Tons and USD MN)
  • Brazil Market Analysis (Tons and USD MN)
  • Argentina Market Analysis (Tons and USD MN)
  • Peru Market Analysis (Tons and USD MN)
  • Chile Market Analysis (Tons and USD MN)
  • Rest of Latin America Market Analysis (Tons and USD MN)
  • Middle East & Africa Market Analysis (Tons and USD MN)
  • Saudi Arabia Market Analysis (Tons and USD MN)
  • UAE Market Analysis (Tons and USD MN)
  • Israel Market Analysis (Tons and USD MN)
  • South Africa Market Analysis (Tons and USD MN)
  • Rest of Middle East and Africa Market Analysis (Tons and USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Cannabinoids Report
  • Market Research Process
  • Market Research Methodology
  • Global Cannabinoids Market Size, by Region (Tons and USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product Type
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product Type (Tons and USD MN)
  • Cannabidiol Market Sales by Geography (Tons and USD MN)
  • Tetrahydrocannabinol Market Sales by Geography (Tons and USD MN)
  • Cannabinol Market Sales by Geography (Tons and USD MN)
  • Others Market Sales by Geography (Tons and USD MN)
  • Global Market Analysis by Application (Tons and USD MN)
  • Medicinal Use (Chronic Pain, Neurological Disorders Management, Oncology, Others) Market Sales by Geography (Tons and USD MN)
  • Non-medical Use Market Sales by Geography (Tons and USD MN)
  • Global Market Analysis by Distribution Channel (Tons and USD MN)
  • Hospital Pharmacies Market Sales by Geography (Tons and USD MN)
  • Retail Pharmacies Market Sales by Geography (Tons and USD MN)
  • Online Stores Market Sales by Geography (Tons and USD MN)
  • Global Market Sales (Tons and USD MN)
  • North America Market Sales (Tons and USD MN)
  • Europe Market Sales (Tons and USD MN)
  • Asia Pacific Market Sales (Tons and USD MN)
  • Latin America Market Sales (Tons and USD MN)
  • Middle East & Africa Market Sales (Tons and USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11219442

The global demand for Cannabinoids Market is presumed to reach the market size of nearly USD 196.4 BN by 2030 from USD 25.54 BN in 2022 with a CAGR of 25.44% under the study period of 2023 - 2030.

Cannabinoids, also known as medical marijuana, treat diseases or improve their symptoms. They are employed in the control of pain, blood pressure, memory, focus, appetite, sensory stimulation, muscular issues, and seizures, among other disorders or health situations. The material is additionally employed in the body care sector as a component of body oils, lotions, and capsules.

MARKET DYNAMICS:

In recent years, the use of cannabis for various medical ailments has gained popularity in the nation. Market expansion is fueled by elements including rising customer preference for products containing cannabinoids and increasing public awareness of cannabis and related products. Favourable government policies around cannabinoids have also attracted more companies to the industry. Additionally, promising research suggesting the benefits of minor and major cannabinoids in treating various health issues has raised public awareness of cannabis use. However, it is anticipated that the high costs of production and extraction, particularly for small cannabinoids, will impede market expansion.

The report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cannabinoids. The growth and trends of Cannabinoids Industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the cannabinoids market report provides detailed data on the segments by analyzing them at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

  • Cannabidiol
  • Tetrahydrocannabinol
  • Cannabinol
  • Others

By Application

  • Medicinal Use (Chronic Pain, Neurological Disorders Management, Oncology, Others)
  • Non-Medical Use

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Stores

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Cannabinoids market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the cannabinoids market include Mylan N.V. (Viatris Inc.), Alkem Labs, GW Pharmaceuticals plc, Tilray Inc., Aurora Cannabis Inc., Canopy Growth Corporation, The Cronos Group. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . CANNABINOIDS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By Distribution Channel
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL CANNABINOIDS MARKET ANALYSIS BY PRODUCT TYPE

  • 6.1 Overview by Product Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product Type
  • 6.4 Cannabidiol Historic and Forecast Sales by Regions
  • 6.5 Tetrahydrocannabinol Historic and Forecast Sales by Regions
  • 6.6 Cannabinol Historic and Forecast Sales by Regions
  • 6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL CANNABINOIDS MARKET ANALYSIS BY APPLICATION

  • 7.1 Overview by Application
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Application
  • 7.4 Medicinal Use (Chronic Pain, Neurological Disorders Management, Oncology, Others) Historic and Forecast Sales by Regions
  • 7.5 Non-medical Use Historic and Forecast Sales by Regions

8 . GLOBAL CANNABINOIDS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 8.1 Overview by Distribution Channel
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Distribution Channel
  • 8.4 Hospital Pharmacies Historic and Forecast Sales by Regions
  • 8.5 Retail Pharmacies Historic and Forecast Sales by Regions
  • 8.6 Online Stores Historic and Forecast Sales by Regions

9 . GLOBAL CANNABINOIDS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE CANNABINOIDS COMPANIES

  • 10.1. Cannabinoids Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF CANNABINOIDS INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Mylan N.V. (Viatris Inc.)
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Alkem Labs
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. GW Pharmaceuticals plc
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. Tilray Inc.
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Aurora Cannabis Inc.
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Canopy Growth Corporation
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. The Cronos Group
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies